Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000494:pharmacology; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D002994:Clofibrate / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007118:Immunoassay; D007383:Intermittent Claudication / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008687:Metformin / Q000494:pharmacology*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009539:Nicotinic Acids / Q000494:pharmacology; D010689:Phlebitis / Q000188:drug therapy; D005082:Physical Exertion; D010958:Plasminogen / Q000032:analysis; D055728:Primary Myelofibrosis / Q000188:drug therapy; D011422:Propionates / Q000494:pharmacology; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D013739:Testosterone / Q000494:pharmacology*; D014042:Tolazamide / Q000494:pharmacology; D014508:Urea / Q000627:therapeutic use
D000614:Aminocaproates; D000924:Anticholesteremic Agents; D007004:Hypoglycemic Agents; D009539:Nicotinic Acids; D011422:Propionates; D013739:Testosterone; D014508:Urea; D005340:Fibrinogen; D010958:Plasminogen; D008687:Metformin; D014042:Tolazamide; D002994:Clofibrate